|
1
|
ICO Information Centre on HPV and Cancer
(HPV Information Centre), . Human Papillomavirus and Related
Diseases Report. Summary Report, 2017. http://www.hpvcentre.net/statistics/reports/XWX.pdfJuly
27–2017
|
|
2
|
Zur Hausen H: Papillomavirus
infections-major cause of human cancers. Biochim Biophys Acta.
1288:F55–F78. 1996.PubMed/NCBI
|
|
3
|
Saslow D, Castle PE, Cox JT, Davey DD,
Einstein MH, Ferris DG, Goldie SJ, Harper DM, Kinney W, Moscicki
AB, et al: American cancer society guideline for human
papillomavirus (HPV) vaccine use to prevent cervical cancer and its
precursors. CA Cancer J Clin. 57:7–28. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Horn LC, Raptis G and Fischer U: Familial
cancer history in patients with carcinoma of the cervix uteri. Eur
J Obstet Gynecol Reprod Biol. 101:54–57. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang Z, Borecki I, Nguyen L, Ma D, Smith
K, Huettner PC, Mutch DG, Herzog TJ, Gibb RK, Powell MA, et al:
CD83 gene polymorphisms increase susceptibility to human invasive
cervical cancer. Cancer Res. 67:11202–11208. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yu KJ, Rader JS, Borecki I, Zhang Z and
Hildesheim A: CD83 Polymorphisms and cervical cancer risk. Gynecol
Oncol. 114:319–322. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shintani T and Klionsky DJ: Autophagy in
health and disease: A double-edged sword. Science. 306:990–995.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ojeda JM, Ampuero S, Rojas P, Prado R,
Allende JE, Barton SA, Chakraborty R and Rothhammer F: p53 codon 72
polymorphism and risk of cervical cancer. Biol Res. 36:279–283.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu S, Lu S, Tao H, Zhang L, Lin W, Shang H
and Xie J: Correlation of polymorphism of IL-8 and MMP-7 with
occurrence and lymph node metastasis of early stage cervical
cancer. J Huazhong Univ Sci Technolog Med Sci. 31:114–119. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Levine B and Kroemer G: Autophagy in the
pathogenesis of disease. Cell. 132:27–42. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ichimura Y, Imamura Y, Emoto K, Umeda M,
Noda T and Ohsumi Y: In vivo and in vitro reconstitution of ATG8
conjugation essential for autophagy. J Biol Chem. 279:40584–40592.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Betin VM, Singleton BK, Parsons SF, Anstee
DJ and Lane JD: Autophagy facilitates organelle clearance during
differentiation of human erythroblasts: Evidence for a role for
ATG4 paralogs during autophagosome maturation. Autophagy.
9:881–893. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wolf J, Dewi DL, Fredebohm J,
Müller-Decker K, Flechtenmacher C, Hoheisel JD and Boettcher M: A
mammosphere formation RNAi screen reveals that ATG4A promotes a
breast cancer stem-like phenotype. Breast Cancer Res. 15:R1092013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
He Q, Lu Y, Hu S, Huang Q, Li S, Huang Y,
Hu Q, Wu L and Chen W: An intron SNP rs807185 in ATG4A decreases
the risk of lung cancer in a southwest Chinese population. Eur J
Cancer Prev. 25:255–258. 2015. View Article : Google Scholar
|
|
15
|
Liao YP, Chen LY, Huang RL, Su PH, Chan
MW, Chang CC, Yu MH, Wang PH, Yen MS, Nephew KP and Lai HC:
Hypomethylation signature of tumor-initiating cells predicts poor
prognosis of ovarian cancer patients. Hum Mol Genet. 23:1894–1906.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ritchie MD, Hahn LW, Roodi N, Bailey LR,
Dupont WD, Parl FF and Moore JH: Multifactor-dimensionality
reduction reveals high-order interactions among estrogen-metabolism
genes in sporadic breast cancer. Am J Hum Genet. 69:138–147. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Purcell S, Neale B, Todd-Brown K, Thomas
L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ
and Sham PC: PLINK: A tool set for whole-genome association and
population-based linkage analyses. Am J Hum Genet. 81:559–575.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Barrett JC, Fry B, Maller J and Daly MJ:
Haploview: Analysis and visualization of LD and haplotype maps.
Bioinformatics. 21:263–265. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Degenhardt K, Mathew R, Beaudoin B, Bray
K, Anderson D, Chen G, Mukherjee C, Shi Y, Gélinas C, Fan Y, et al:
Autophagy promotes tumor cell survival and restricts necrosis,
inflammation, and tumorigenesis. Cancer Cell. 10:51–64. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Quesada V, Ordóñez GR, Sánchez LM, Puente
XS and López-Otín C: The Degradome database: Mammalian proteases
and diseases of proteolysis. Nucleic Acids Res. 37(Database Issue):
D239–D243. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Skytte Rasmussen M, Mouilleron S, Kumar
Shrestha B, Wirth M, Lee R, Bowitz Larsen K, Abudu Princely Y,
O'Reilly N, Sjøttem E, Tooze SA, et al: ATG4B contains a C-terminal
LIR motif important for binding and efficient cleavage of mammalian
orthologs of yeast ATG8. Autophagy. 13:834–853. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rothe K, Lin H, Lin KB, Leung A, Wang HM,
Malekesmaeili M, Brinkman RR, Forrest DL, Gorski SM and Jiang X:
The core autophagy protein ATG4B is a potential biomarker and
therapeutic target in CML stem/progenitor cells. Blood.
123:3622–3634. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fernández ÁF and López-Otín C: The
functional and pathologic relevance of autophagy proteases. J Clin
Invest. 125:33–41. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen Y, Liu XR, Yin YQ, Lee CJ, Wang FT,
Liu HQ, Wu XT and Liu J: Unravelling the multifaceted roles of Atg
proteins to improve cancer therapy. Cell Prolif. 47:105–112. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Brinar M, Vermeire S, Cleynen I, Lemmens
B, Sagaert X, Henckaerts L, Van Assche G, Geboes K, Rutgeerts P and
De Hertogh G: Genetic variants in autophagy-related genes and
granuloma formation in a cohort of surgically treated Crohn's
disease patients. J Crohns Colitis. 6:43–50. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ortiz-Cuaran S, Cox D, Villar S, Friesen
MD, Durand G, Chabrier A, Khuhaprema T, Sangrajrang S, Ognjanovic
S, Groopman JD, et al: Association between TP53 R249S mutation and
polymorphisms in TP53 intron 1 in hepatocellular carcinoma. Genes
Chromosomes Cancer. 52:912–919. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gao X, Yang J, Wang M and Zhang J: TCF21
genetic polymorphisms and breast cancer risk in Chinese women.
Oncotarget. 7:55757–55764. 2016.PubMed/NCBI
|
|
28
|
Zagouri F, Sergentanis TN, Chrysikos D,
Filipits M and Bartsch R: Molecularly targeted therapies in
cervical cancer. A systematic review. Gynecol Oncol. 126:291–303.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu B, Ding JF, Luo J, Lu L, Yang F and
Tan XD: Seven protective miRNA signatures for prognosis of cervical
cancer. Oncotarget. 7:56690–56698. 2016.PubMed/NCBI
|
|
30
|
Dong SS, Hu WX, Yang TL, Chen XF, Yan H,
Chen XD, Tan LJ, Tian Q, Deng HW and Guo Y: SNP-SNP interactions
between WNT4 and WNT5A were associated with obesity related traits
in Han Chinese Population. Sci Rep. 7:439392017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Molano M, Moreno-Acosta P, Morales N,
Burgos M, Buitrago L, Gamboa O, Alvarez R, Garland SM, Tabrizi SN,
Steenbergen RD and Mejía JC: Association between type-specific HPV
Infections and hTERT DNA methylation in patients with invasive
cervical cancer. Cancer Genomics Proteomics. 13:483–491. 2016.
View Article : Google Scholar : PubMed/NCBI
|
